Displaying drugs 2726 - 2750 of 2809 in total
Aspartyl-Adenosine-5'-Monophosphate
Experimental
Sinefungin
Sinefungin is a solid. This compound belongs to the purine nucleosides and analogues. These are compounds comprising a purine base attached to a sugar. The proteins that adenosyl-ornithine target include RdmB, modification methylase TaqI, rRNA (adenine-N6-)-methyltransferase, and modification methylase RsrI.
Experimental
5,6-dihydroxy-NADP
Experimental
Dephospho Coenzyme A
Experimental
Skf 107457
Experimental
PZ-128
PZ-128 has been used in trials studying the prevention and treatment of Heart Diseases, Coronary Disease, Arteriosclerosis, Vascular Diseases, and Myocardial Ischemia, among others.
Investigational
3-Amino-4,5-Dihydroxy-Cyclohex-1-Enecarboxylate
Experimental
S-adenosyl-L-homocysteine
5'-S-(3-Amino-3-carboxypropyl)-5'-thioadenosine. Formed from S-adenosylmethionine after transmethylation reactions.
Experimental
Selenazole-4-carboxyamide-adenine dinucleotide
Experimental
5,10-Dimethylene Tetrahydromethanopterin
Experimental
C-1027 Aromatized chromophore
Experimental
Clorobiocin
Clorobiocin is an aminocoumarin antibiotic, similar to novobiocin and coumermycin A1.
Experimental
Apstatin
Experimental
TT-232
Tln 232 is under investigation in clinical trial NCT00422786 (Phase II Study of CAP-232 in Patients With Refractory Metastatic Renal Cell Carcinoma).
Investigational
6-hydroxy-FAD
Experimental
GDP-alpha-D-mannuronic acid
Experimental
Cpad
Experimental
Histidyl-Adenosine Monophosphate
Experimental
Adenylosuccinic acid
Experimental
ABT-510
ABT-510 is a peptide mimetic of thrombospondin-1 (TSP-1), blocks angiogenesis in vitro and in vivo, and slows tumor growth. It is developed by Abbott Laboratories for the treatment of Solid Tumors, Lymphoma and Melanoma.
Investigational
Displaying drugs 2726 - 2750 of 2809 in total